Eculizumab: Safety and Efficacy After 17 Months of Treatment in a Renal Transplant Patient With Recurrent Atypical Hemolytic-Uremic Syndrome: Case Report
2010 ◽
Vol 42
(10)
◽
pp. 4353-4355
◽
2009 ◽
Vol 9
(11)
◽
pp. 2644-2645
◽
1995 ◽
Vol 29
(4)
◽
pp. 507-510
◽
1995 ◽
Vol 153
(4)
◽
pp. 1211-1213
◽
2017 ◽
Vol 49
(1)
◽
pp. 188-192
◽
2009 ◽
Vol 41
(8)
◽
pp. 3437-3439
◽